Randomized phase III trial of fludarabine plus cyclophosphamide with or without oblimersen sodium (Bcl-2 antisense) in patients with relapsed or refractory chronic lymphocytic leukemia

Susan O'Brien, Joseph O. Moore, Thomas E. Boyd, Loree M. Larratt, Aleksander Skotnicki, Benjamin Koziner, Asher A. Chanan-Khan, John F. Seymour, R. Gregory Bociek, Steve Pavletic, Kanti R. Rai

Research output: Contribution to journal › Article › peer-review

264 Scopus citations

Fingerprint

Dive into the research topics of 'Randomized phase III trial of fludarabine plus cyclophosphamide with or without oblimersen sodium (Bcl-2 antisense) in patients with relapsed or refractory chronic lymphocytic leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences